Article

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors

2026-07-29

Abstract excerpt

The role of comprehensive genomic profiling for therapeutic decision-making is established in high-risk pediatric cancers, but its utility in rare and diagnostically challenging tumors is unclear. Here we report 123 non-high-risk patients enrolled in the Australian ZERO Childhood Cancer Program for diagnostic uncertainty, clinician request to address a specific molecular query, or other rare tumors. Comprehensive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e95a7a77-3724-52f8-ab5a-4ef5699cb37b
DOI: 10.64898/2026.07.25.26358936

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumorsDOI 10.64898/2026.07.25.26358936Read

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumorsSemantic proximity Read

Molecular Profiling of Hard-to-Treat Childhood and Adolescent CancersSemantic proximity Read

Data-driven approaches to advance research and clinical care for pediatric cancer.Semantic proximity Read

Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.Semantic proximity Read

Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.Semantic proximity Read

Genomics-Driven Precision Medicine in Pediatric Solid TumorsSemantic proximity Read

Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Semantic proximity Read

Real-World Performance of Integrative Clinical Genomics in Pediatric Precision OncologySemantic proximity Read

An institutional review of genomic sequencing in pediatric solid tumors.Semantic proximity Read

Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.Semantic proximity Read

Integrating genomics into clinical pediatric oncology using the molecular tumor board at the Memorial Sloan Kettering Cancer CenterSemantic proximity Read

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.Semantic proximity Read